A phase 1 study of SGN-BB228 in advanced melanoma and other solid tumors

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Solid Tumors
    Melanoma
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    In order to participate the following conditions must be met:
    1. In the dose-expansion cohorts, subjects will have one of the following histologically or cytologically confirmed metastatic or unresectable solid malignancy within one of the tumor

You may not be eligible for this study if the following are true:

  • You will not be able to participate in the study if you have had:
    1. History of another malignancy within 3 years before the first dose of study drug, or any evidence of residual disease from a previously diagnosed malignancy.
    2. Known acti


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.